News

The Nencki Institute is a partner in the PACMAN project – 73 million PLN  for new cancer therapies

A scientific consortium involving the Nencki Institute of Experimental Biology PAS has received nearly PLN 73 million to implement the PACMAN project (Personalized Antibody-Drug Conjugates Activated by Matrix Metalloproteinases for Solid Tumors). The PACMAN project received the highest rating from an international panel of experts and was the only one to receive funding in the fourth edition of the WIB (Virtual Research Institute) competition. The project will last 4.5 years and will be ...